Results 111 to 120 of about 59,813 (197)
Identifying novel prodromal symptoms of eclampsia: A two-country, case-control study. [PDF]
Hastie R +12 more
europepmc +1 more source
ABSTRACT Background Adverse maternal and perinatal outcomes such as preeclampsia, small‐for‐gestational age (SGA) and preterm birth remain major global health concerns. Beyond known high‐risk placental features, emerging evidence suggests lateral placenta to be associated with impaired uteroplacental blood flow resulting in placenta dysfunction and ...
Joseph Arkorful +6 more
wiley +1 more source
Renewed focus on reducing the burden of pre-eclampsia. [PDF]
Farrar J +16 more
europepmc +1 more source
Psychiatric History and Postpartum Depression: The Mediating Role of Obstetric Complications
ABSTRACT Introduction Psychiatric history is the strongest risk factor for postpartum depression (PPD). Obstetric complications, more prevalent among women with a psychiatric history, are also independent risk factors. However, the mechanisms linking these factors to PPD remain unclear.
Mette‐Marie Zacher Kjeldsen +9 more
wiley +1 more source
Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study. [PDF]
Nandi M, Mondal R.
europepmc +1 more source
Women with type 1 diabetes had higher odds for most adverse pregnancy outcomes. In 2015–2021 compared to 1999–2014, women with type 1 diabetes had a notable reduction in congenital malformations, while immigrant women with type 1 diabetes had increased odds of delivering large for gestational age infants.
Astrid Melteig Stalheim +7 more
wiley +1 more source
WHO recommendations for pregnancy and postpartum care should include hypertensive disorders of pregnancy. [PDF]
Miltenburg AS +7 more
europepmc +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Peter von Dadelszen +4 more
wiley +1 more source
In pregnant women with new‐onset hypertension starting antihypertensives, some achieve tight BP control within a week (Group 1‐blue line), while others respond slower (Group 2‐red line). Group 1 showed higher Log10PLGF levels, but Log10sFlt‐1 did not differ between groups. Over time, Log10PLGF declined in both groups, while Log10sFlt‐1 remained stable.
Edward Tyrell +4 more
wiley +1 more source
<i>In vitro</i> evidence that plasma of women with eclampsia disrupts the blood-brain barrier. [PDF]
Acurio J +8 more
europepmc +1 more source

